Sontag Advisory »

Theriva Biologics shares owned by Sontag Advisory

Quarter-by-quarter ownership of Theriva Biologics (TOVX) shares owned by Sontag Advisory from 13F filings

Historical chart of Sontag Advisory investment in Theriva Biologics

Tip: Access up to 7 years of quarterly data

All positions including Theriva Biologics held by Sontag Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theriva Biologics by Sontag Advisory

Quarter filed Position value Share count Share price at filing
2025-09-30 $1 2 0.50

More positions owned by Sontag Advisory

iShares Core S&P 500 ETF Etf (IVV)
Vanguard MSCI EAFE ETF Etf (VEA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
iShares Core S&P Mid-Cap ETF Etf (IJH)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Index Fds Total Stk Mkt (VTI)
Schwab International Equity ETF Etf (SCHF)
Vanguard FTSE Emerging Markets ETF Etf (VWO)
Vanguard Index Fds Growth Etf (VUG)
iShares Core S&P Small-Cap ETF Etf (IJR)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Extended Market ETF Etf (VXF)
Vanguard Index Fds Large Cap Etf (VV)

View all positions for Sontag Advisory

Top funds holding Theriva Biologics

Ikarian Capital
Two Sigma Investments
Virtu Financial
Jane Street
Boothbay Fund Management
XTX Topco
Geode Capital Management
Two Sigma Advisers
UBS Group
Vanguard Group
Hrt Financial
BlackRock
Advisor Group Holdings
Clear Street
SBI Securities

View all funds holding Theriva Biologics